Besides this result with the Quick score and ITAC samples, higher gene expression of EIF6 is associated with tumour progression in some cancer types [29], especially in colorectal cancer [26] and in colon cancer [26], in lung metastases [30], in acute promyelocytic leukaemia [31], in ovarian serous carcinoma [32] and in malignant mesothelioma [33]. This evidence concerns the gene EIF6 and colorectal cancer.